台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    96.1
  • 漲跌
    ▲0.9
  • 漲幅
    +0.95%
  • 成交量
    522
  • 產業
    上櫃 生技醫療類股
  • 306人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-第一金-員林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

第一金-員林 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/09197.70198.1094.6001,3410.00%
2025/01/0800.0013102.50103.00-131,299-1.00%
2025/01/0700.005101.80101.50-51,275-0.39%
2025/01/062101.253101.17101.50-11,259-0.08%
2025/01/0300.00897.1598.30-81,240-0.64%
2025/01/0200.00194.5093.60-11,235-0.08%
2024/12/27192.0000.0092.0011,2230.08%
2024/12/2500.00290.2591.00-21,214-0.16%
2024/12/24187.4000.0087.4011,2070.08%
2024/12/19287.5000.0087.4021,2100.17%
2024/12/18188.8000.0088.8011,2200.08%
2024/12/17286.3000.0086.7021,2230.16%
2024/12/16188.8000.0086.3011,2160.08%
2024/12/12190.0000.0090.2011,1990.08%
2024/12/11191.5000.0090.6011,1930.08%
2024/12/02295.9000.0094.4021,1580.17%
2024/11/2900.00198.2097.50-11,136-0.09%
2024/11/21196.50196.6096.2001,0210.00%
2024/11/20497.8800.0096.5041,0180.39%
2024/11/1510100.502100.0099.9089890.81%
2024/11/1300.007106.43106.50-7946-0.74%
2024/11/0500.004106.75106.00-4782-0.51%
2024/11/011101.5012108.46105.00-11730-1.51%
2024/10/281102.0000.00102.0015760.17%
2024/10/2400.003100.0098.30-3494-0.61%
2024/10/23392.1000.0093.7034240.71%
2024/10/07088.8000.0088.8005060.00%
2024/10/04089.1000.0088.7005410.00%
2024/08/2800.00187.0086.60-1729-0.14%
2024/08/2700.00186.7086.50-1734-0.14%
2024/08/2100.00186.6086.60-1746-0.13%
2024/08/1600.00684.6284.60-6743-0.81%
2024/08/1500.00584.5084.50-5745-0.67%
2024/08/051083.5000.0083.00107641.31%
2024/07/30293.4000.0093.6027360.27%
2024/07/2900.00295.1094.50-2736-0.27%
2024/07/15197.5000.0098.4016630.15%
2024/07/1200.00296.7095.60-2648-0.31%
2024/07/0800.002100.50100.50-2655-0.31%
2024/07/0100.001101.00101.00-1610-0.16%
2024/06/2700.00696.3095.70-6582-1.03%
2024/06/2400.00193.2093.20-1589-0.17%
2024/06/1400.000.195.9095.30-0.1655-0.01%
2024/06/0400.00291.4090.80-2647-0.31%
2024/05/2800.000.592.5092.30-0.5760-0.07%
2024/05/14296.00295.5094.3001,0430.00%
2024/05/10193.3000.0093.3011,0520.10%
2024/05/0900.00393.4093.30-31,072-0.28%
2024/04/2900.000.195.2095.30-0.11,430-0.01%
2024/04/220.188.0000.0088.000.11,5120.00%
2024/04/162.192.7900.0091.002.11,5570.13%
2024/04/150.194.4000.0094.100.11,5650.00%
2024/03/2800.00199.6099.40-11,839-0.05%
2024/03/08296.30399.7095.10-11,924-0.05%
2024/03/07897.20195.4099.3071,9300.36%
2024/03/06298.3000.0098.1021,9370.10%
2024/03/0400.001100.50100.50-11,924-0.05%
2024/03/0100.000.1103.00101.50-0.11,9390.00%
2024/02/2700.001104.50103.00-11,995-0.05%
2024/02/2000.001101.00101.50-12,058-0.05%
2024/02/165102.401102.00102.0042,0960.19%
2024/02/152111.253110.00110.50-12,060-0.05%
2024/02/0200.002105.50105.50-22,216-0.09%
2024/02/011107.002107.25107.00-12,281-0.04%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章